{"id":2195873,"date":"2022-05-03T08:55:39","date_gmt":"2022-05-02T23:55:39","guid":{"rendered":"https:\/\/www.nknews.org\/pro\/?p=2195873"},"modified":"2023-04-05T16:12:37","modified_gmt":"2023-04-05T07:12:37","slug":"how-politicization-of-south-koreas-covid-19-response-has-undercut-its-successes","status":"publish","type":"post","link":"https:\/\/koreapro.org\/2022\/05\/how-politicization-of-south-koreas-covid-19-response-has-undercut-its-successes\/","title":{"rendered":"How politicization of South Korea\u2019s COVID-19 response has undercut its successes"},"content":{"rendered":"
There\u2019s no denying that South Korea initially managed to keep a lid on the virus by responding stringently and flexibly when COVID-19 first broke out. Based on aggressive testing, tracing and treatment, the country quickly isolated infected patients and implemented social distancing policies to limit daily infection numbers.<\/span><\/p>\n The strategy seemed to work, and as the world applauded the country\u2019s success in flattening the curve, the <\/span>Moon administration reveled in the attention, dubbing its response \u201cK-Quarantine.\u201d\u00a0<\/span><\/p>\n However, it was clear by autumn 2020 that the pandemic would stretch on and likely worsen over the colder months. It was also clear that COVID-19 vaccines would be readily available sooner than many expected after rapid development.\u00a0<\/span><\/p>\n But South Korea did not move to seal deals with major vaccine developers, opting instead to spend millions promoting <\/span>K-Quarantine<\/span><\/a> as the global standard for <\/span>public health<\/span><\/a>.<\/span> The Moon administration <\/span>seemed to believe<\/span><\/a> South Korea\u2019s COVID-19 response was so successful that vaccine imports were not needed and that the country could develop its own indigenous vaccines, despite medical experts\u2019 skepticism.<\/span><\/p>\n To keep this dream alive, the South Korean government chose to enforce ever-increasing social distancing restrictions and sow doubt about the efficacy and safety of foreign vaccines. There is \u201cno rush\u201d to procure mRNA vaccines from abroad, said Ki Mo-ran, a professor at the National Cancer Center and key <\/span>public health adviser<\/span><\/a> to the Moon administration, as recently as 2021.<\/span><\/p>\n The government did allow some groups to get vaccinated beginning in February that year \u2014 likely due to public pressure as the U.S. and other countries made vaccines widely available. But it was months before enough supplies were procured for the general population. Once the widescale rollout began, the K-Vaccine drive quietly ebbed away.\u00a0 Now in the third year of the pandemic, not a single K-vaccine has been approved and <\/span>prospects<\/span><\/a> for approval at any time in the future <\/span>appear dim<\/span><\/a>.<\/span><\/p>\n The result of the administration\u2019s decision to ignore experts who disagreed with its overly optimistic narrative about vaccine development is that nearly <\/span>half of the country<\/span><\/a> does not trust the presidential office or elected offices to lead the pandemic response. Trust in public health authorities, such as the Korea Disease Control and Prevention Agency (KDCA), has fallen by around 20 percentage points since 2020.<\/span><\/p>\n